MedTrace Logo

Hyaluronic Matrix Efficacy for Maxillary Sinus Augmentation

NCT02692261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2016-02-26

No results posted yet for this study

Summary

Sinus augmentation is a predictable method when alveolar bone height is not sufficient for dental implant placement in posterior maxillary alveolar region..The aim of this prospective, randomized, controlled clinical study is comparison of hyaluronic acid originated matrix and equine derived xenograft with only xenograft use in sinus augmentation by micro computed tomography and histomorphometry.

Conditions

  • Sinus; Dental

Interventions

PROCEDURE

Maxillary Sinus Augmentation

Each 0.5 cc Collagenated Heterolog Bone Graft, mixed with two bundles of Hyalossᵀᴹ matrix and a few drops of sterile saline solution

PROCEDURE

Maxillary Sinus Augmentation

Control group sinuses filled with heterolog bone graft alone

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Feriha Caglayan, Professor · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
33 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-06-30
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02692261 on ClinicalTrials.gov